Sanofi SA To Acquire Principia Biopharma Inc - M&A Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi to Acquire Principia Biopharma Conference Call. I would now like to turn the call over to Felix Lauscher of Sanofi Investor Relations. Please go ahead, sir.
Good morning, and good afternoon to everyone. Thank you for joining us on the call to review Sanofi's acquisition of Principia Biopharma. As usual, you can find the slides of this call on the Investors page of our website at sanofi.com.
Moving to Slide 2. I would like to remind you that information presented in this call contain forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our Document d'Enregistrement Universel for a description of these risk factors.
On Slide 3, I would like to draw your attention to additional disclosure regarding the tender offer for Principia Biopharma in the U.S.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
